• Login
    View Item 
    •   Knowledge Repository Home
    • School of Basic and Applied Sciences
    • Department of Biochemistry and Microbial Sciences
    • Biochemistry and Microbial Sciences-Research Publications
    • View Item
    •   // Knowledge Repository Home
    • // School of Basic and Applied Sciences
    • // Department of Biochemistry and Microbial Sciences
    • // Biochemistry and Microbial Sciences-Research Publications
    • // View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    Knowledge RepositorySchools & CollectionsBy Issue DateAuthorsTitlesSubjectsBy Submit DateThis CollectionBy Issue DateAuthorsTitlesSubjectsBy Submit Date

    My Account

    LoginRegister

    Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies

    Thumbnail
    Date
    2020
    Author
    Gupta, S
    Singh, A.K
    Kushwaha, P.P
    Prajapati, K.S
    Shuaib, M
    Senapati, S
    Kumar, S.
    Metadata
    Show full item record
    Abstract
    Coronaviruses are contagious pathogens primarily responsible for respiratory and intestinal infections. Research efforts to develop antiviral agents against coronavirus demonstrated the main protease (Mpro) protein may represent effective drug target. X-ray crystallographic structure of the SARS-CoV2 Mpro protein demonstrated the significance of Glu166, Cys141, and His41 residues involved in protein dimerization and its catalytic function. We performed in silico screening of compounds from Curcuma longa L. (Zingiberaceae family) against Mpro protein inhibition. Employing a combination of molecular docking, scoring functions, and molecular dynamics simulations, 267 compounds were screened by docking on Mpro crystallographic structure. Docking score and interaction profile analysis exhibited strong binding on the Mpro catalytic domain with compounds C1 (1E,6E)-1,2,6,7-tetrahydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione) and C2 (4Z,6E)?1,5?dihydroxy?1,7?bis(4?hydroxyphenyl)hepta?4,6?dien?3?one as lead agents. Compound C1 and C2 showed minimum binding score (�9.08 and �8.07 kcal/mole) against Mpro protein in comparison to shikonin and lopinavir (? ?5.4 kcal/mole) a standard Mpro inhibitor. Furthermore, principal component analysis, free energy landscape and protein-ligand energy calculation studies revealed that these two compounds strongly bind to the catalytic core of the Mpro protein with higher efficacy than lopinavir, a standard antiretroviral of the protease inhibitor class. Taken together, this structure based optimization has provided lead on two natural Mpro inhibitors for further testing and development as therapeutics against human coronavirus. Communicated by Ramaswamy H. Sarma. � 2020, � 2020 Informa UK Limited, trading as Taylor & Francis Group.
    Journal
    Journal of Biomolecular Structure and Dynamics
    Access Type
    Open Access
    URI
    http://172.158.2.16/handle/32116/2701
    URL
    https://www.tandfonline.com/doi/full/10.1080/07391102.2020.1776157
    DOI
    10.1080/07391102.2020.1776157
    Collections
    • Biochemistry and Microbial Sciences-Research Publications [88]
    • Human Genetics and Molecular Medicine-Research Publications [137]

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Initiatives by University Library 
    Central University of Punjab
     

     


    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Initiatives by University Library 
    Central University of Punjab